Article Details

Paragon Biosciences' CEO Jeff Aronin Announces $35 Million Series C Preferred Stock Raise for ...

Retrieved on: 2021-04-19 17:03:45

Tags for this article:

Click the tags to see associated articles and topics

Paragon Biosciences' CEO Jeff Aronin Announces $35 Million Series C Preferred Stock Raise for .... View article details on hiswai:

Excerpt

... approximately $1 billion in novel therapies, including cell and gene therapy, synthetic biology utilizing artificial intelligence and biopharmaceuticals.

Article found on: www.healthtechzone.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up